Who Exports Diphenhydramine from India — 178 Suppliers Behind a $32.0M Market
India's diphenhydramine export market is supplied by 178 active exporters who collectively shipped $32.0M across 1,430 shipments. ELYSIUM PHARMACEUTICALS LTD leads with a 19.0% market share, followed by MICRO LABS LIMITED and REAL DRUGS PRIVATE LIMITED. The top 5 suppliers together control 59.9% of total export value, reflecting a moderately competitive market structure.
Top Diphenhydramine Exporters from India — Ranked by Export Value
ELYSIUM PHARMACEUTICALS LTD is the leading diphenhydramine exporter from India, holding a 19.0% share of the $32.0M market across 1,430 shipments from 178 exporters. The top 5 suppliers — ELYSIUM PHARMACEUTICALS LTD, MICRO LABS LIMITED, REAL DRUGS PRIVATE LIMITED, GRANULES INDIA LIMITED, TRUECARE BIOMEDIX — collectively control 59.9% of total export value, indicating a moderately concentrated market. Individual shares are: ELYSIUM PHARMACEUTICALS LTD (19.0%), MICRO LABS LIMITED (17.2%), REAL DRUGS PRIVATE LIMITED (9.0%), GRANULES INDIA LIMITED (7.8%), TRUECARE BIOMEDIX (6.9%).
Top Diphenhydramine Exporters from India
Ranked by export value · 178 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ELYSIUM PHARMACEUTICALS LTD ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/ML | $6.1M | 1 | 19.0% |
| 2 | MICRO LABS LIMITED ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/MLPHENDREPHIN 50MG/ML TAX INV NO:714201282/29.03.2025 | $5.5M | 2 | 17.2% |
| 3 | REAL DRUGS PRIVATE LIMITED | $2.9M | 1 | 9.0% |
| 4 | GRANULES INDIA LIMITED ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/ML | $2.5M | 1 | 7.8% |
| 5 | TRUECARE BIOMEDIX ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/ML | $2.2M | 1 | 6.9% |
| 6 | ELYSIUM PHARMACEUTICALS LIMITED ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/ML | $1.6M | 1 | 5.0% |
| 7 | TRUESTAR ENTERPRISE PRIVATE LIMITED | $930.0K | 3 | 2.9% |
| 8 | JMBS HEALTHCARE | $802.6K | 1 | 2.5% |
| 9 | TRUE CARE BIOMEDIX ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/ML | $709.8K | 1 | 2.2% |
| 10 | A V GLOBAL CO ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLDIPHENHYDRAMINE HCL INJECTION USP 50MG/MLDIPHENHYDRAMINA CLORHI 50MG CAPSULES , PACK: 100X10'S | $545.8K | 2 | 1.7% |
| 11 | MANGAL MURTI ENTERPRISES | $542.4K | 3 | 1.7% |
| 12 | MEDICAMEN BIOTECH LIMITED DIPHENHYDRAMINE ORAL SOLUTION BPDIPHENHYDRAMINE ORAL SOLUTION BP 12.5 MG | $519.8K | 2 | 1.6% |
| 13 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED DIPHENHYDRAMINE ORAL SOLUTION BPDIPHENHYDRAMINE ORAL SOLUTION BP 12.5 MGBETASLEEP CAPSULES (DIPHENHYDRAMINE HYDR | $449.0K | 5 | 1.4% |
| 14 | WELCOME PHARMA | $407.7K | 1 | 1.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Diphenhydramine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| ELYSIUM PHARMACEUTICALS LIMITED | Approved | Yes (Certified on 6/ | No | 1 | FDA inspection on January 16, 2023, resulted in a Form 483. |
| MICRO LABS LIMITED | Approved | Yes (Certified on 9/ | Yes | Not specified | WHO-GMP certification granted on 9/3/2007. |
| GRANULES INDIA LIMITED | Approved | Yes | Yes | Not specified | FDA approval and WHO-GMP certification confirmed. |
| MEDICAMEN BIOTECH LIMITED | Approved | Yes | No | Not specified | WHO-GMP certification confirmed. |
| CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED | Approved | Yes | No | Not specified | WHO-GMP certification confirmed. |
| WELCOME PHARMA | Approved | Yes | No | Not specified | WHO-GMP certification confirmed. |
TransData Nexus reviewed the regulatory standing of 6 leading Diphenhydramine exporters from India. 6 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Diphenhydramine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the nation's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone in December 2019, further solidifies its status as a pharmaceutical hub.
This concentration of bulk drug manufacturers positions Hyderabad as a strategic location for sourcing Active Pharmaceutical Ingredients (APIs) like Diphenhydramine. The city's robust infrastructure and skilled workforce enhance its appeal for pharmaceutical production and export activities.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output.
Vadodara, in particular, is home to companies like Alembic Pharmaceuticals, which specializes in formulations across various therapeutic areas. The region's focus on formulations makes it a key area for sourcing finished Diphenhydramine products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai's strategic coastal location and well-developed port facilities facilitate efficient international shipping. The region hosts numerous pharmaceutical companies with export-oriented operations, leveraging the logistical advantages to distribute products like Diphenhydramine globally.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, primarily due to favorable tax incentives. The region offers benefits such as excise duty exemptions and income tax holidays, attracting numerous pharmaceutical companies. This environment supports cost-effective production of pharmaceuticals, including Diphenhydramine, making it an attractive sourcing destination.
5Sourcing Recommendations
- Leverage Hyderabad's API Production: Utilize Hyderabad's extensive bulk drug manufacturing capabilities to source high-quality Diphenhydramine APIs.
- Engage with Gujarat's Formulation Experts: Collaborate with companies in the Ahmedabad-Vadodara corridor for access to advanced Diphenhydramine formulations.
- Optimize Export Logistics via Mumbai: Utilize Mumbai's port infrastructure to streamline the export process of Diphenhydramine products to international markets.
- Consider Cost Benefits in Baddi-Nalagarh: Explore manufacturing partnerships in Baddi-Nalagarh to take advantage of tax incentives, potentially reducing production costs for Diphenhydramine.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Diphenhydramine exporters from India
Akums Drugs and Pharmaceuticals Limited — Akums Drugs and Pharmaceuticals Limited launches IPO
Akums Drugs and Pharmaceuticals Limited, a leading contract development and manufacturing organization (CDMO), initiated its IPO on August 6, 2024, aiming to raise capital for expansion and operational enhancements. - IMPACT: This IPO may enhance Akums' manufacturing capabilities, potentially influencing the competitive landscape for Diphenhydramine exports.
Impact: This IPO may enhance Akums' manufacturing capabilities, potentially influencing the competitive landscape for Diphenhydramine exports.
Micro Labs Limited — Income Tax Department investigates Micro Labs Limited
In July 2022, the Indian Income Tax Department conducted raids on multiple premises of Micro Labs Limited, including offices and promoters' residences across multiple states, in connection with allegations of tax evasion and unaccounted distribution of freebies to medical professionals. - IMPACT: The investigation could affect Micro Labs' operational focus, potentially impacting its Diphenhydramine export activities.
Impact: The investigation could affect Micro Labs' operational focus, potentially impacting its Diphenhydramine export activities.
Neuland Laboratories Limited — Neuland Laboratories approves ₹342 crore capex to enhance capacity
Neuland Laboratories Limited approved a capital expenditure of ₹342 crore to enhance the capacity of two of its manufacturing units, aiming to meet growing demand and expand its product portfolio. - IMPACT: This expansion may increase Neuland's production capabilities, potentially affecting the supply dynamics of Diphenhydramine exports.
Impact: This expansion may increase Neuland's production capabilities, potentially affecting the supply dynamics of Diphenhydramine exports.
Common Questions — Diphenhydramine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which diphenhydramine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ELYSIUM PHARMACEUTICALS LTD leads with 136 recorded shipments worth $6.1M. MICRO LABS LIMITED (38 shipments) and REAL DRUGS PRIVATE LIMITED (54 shipments) are also established high-volume exporters.
Q How many diphenhydramine manufacturers are there in India?
India has 178 active diphenhydramine exporters with a combined export market of $32.0M across 1,430 shipments to 82 countries. The top 5 suppliers hold 59.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for diphenhydramine from India?
Average FOB unit price: $21.80 per unit, ranging from $0.00 to $686.92. Average shipment value: $22.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 178 verified Indian exporters of Diphenhydramine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,430 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 82 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,430 Verified Shipments
178 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists